Literature DB >> 15306217

Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model.

Andrew J Carter1, Meenakshi Aggarwal, Gregory A Kopia, Fermin Tio, Philip S Tsao, Ron Kolata, Alan C Yeung, Gerald Llanos, John Dooley, Robert Falotico.   

Abstract

BACKGROUND: Stent-based delivery of sirolimus (SRL) has shown reduction in neointimal hyperplasia and restenosis. The purpose of this study was to evaluate the chronic vascular response and the expression of cell cycle regulators after SRL-eluting stent implantation in a porcine coronary model.
METHODS: Forty-nine pigs underwent placement of 109 oversized stents (control, n=54, SRL (140 microg/cm(2)), n=55) in the coronary arteries with histologic analysis and Western blot (PCNA, p27(kip1), CD45, MCP-1, IL-2, IL-6, TNF-beta) at 3, 30, 90 or 180 days.
RESULTS: At 3 days, the mean thrombus area was similar for control (0.38+/-0.19 mm(2)) and SRL (0.29+/-0.09 mm(2)) stents. After 30 days, the mean neointimal area was significantly less for the SRL (1.40+/-0.35 mm(2)) versus the control stents (2.94+/-1.28 mm(2), p<0.001). At 90 and 180 days, the mean neointimal area was similar for the SRL (3.03+/-0.92 and 3.34+/-0.99 mm(2)) as compared with control stents (3.45+/-1.09 and 3.65+/-1.23 mm(2)). Western blot analysis demonstrated an increased expression of p27(kip1) in the vessel wall at 90 days for the SRL versus control stents (p=0.05) but with increased levels of PCNA in the SRL as compared with control stents (p=0.003).
CONCLUSION: SRL-eluting stents favorably modulate neointimal formation for 30 days in the porcine coronary model. Long-term inhibition of neointimal hyperplasia is not sustained presumably due to delayed cellular proliferation despite increased levels of the cyclin-dependent kinase p27(kip1) in the vessel wall.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15306217     DOI: 10.1016/j.cardiores.2004.04.029

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  44 in total

1.  Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold.

Authors:  Salvatore Brugaletta; Hector M Garcia-Garcia; Scot Garg; Josep Gomez-Lara; Roberto Diletti; Yoshinobu Onuma; Robert Jan van Geuns; Dougal McClean; Dariusz Dudek; Leif Thuesen; Bernard Chevalier; Stephan Windecker; Robert Whitbourn; Cecile Dorange; Karine Miquel-Hebert; Krishnankutty Sudhir; John A Ormiston; Patrick W Serruys
Journal:  Int J Cardiovasc Imaging       Date:  2010-10-13       Impact factor: 2.357

2.  Bisphosphonate-mediated gene vector delivery from the metal surfaces of stents.

Authors:  Ilia Fishbein; Ivan S Alferiev; Origene Nyanguile; Richard Gaster; John M Vohs; Gordon S Wong; Howard Felderman; I-Wei Chen; Hoon Choi; Robert L Wilensky; Robert J Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-21       Impact factor: 11.205

Review 3.  Delivery of large biopharmaceuticals from cardiovascular stents: a review.

Authors:  Hironobu Takahashi; Didier Letourneur; David W Grainger
Journal:  Biomacromolecules       Date:  2007-10-12       Impact factor: 6.988

4.  A new polymer-free drug-eluting stent with nanocarriers eluting sirolimus from stent-plus-balloon compared with bare-metal stent and with biolimus A9 eluting stent in porcine coronary arteries.

Authors:  Celso K Takimura; Micheli Z Galon; Paulo S Gutierrez; Prakash Sojitra; Ashwin Vyas; Manish Doshi; Pedro A Lemos
Journal:  Cardiovasc Diagn Ther       Date:  2015-04

5.  Hematopoietic stem cell capture and directional differentiation into vascular endothelial cells for metal stent-coated chitosan/hyaluronic acid loading CD133 antibody.

Authors:  Shixuan Zhang; Fan Zhang; Bo Feng; Qingyu Fan; Feng Yang; Debin Shang; Jinghan Sui; Hong Zhao
Journal:  Tissue Eng Part A       Date:  2014-12-23       Impact factor: 3.845

6.  Comparative study of tacrolimus and paclitaxel stent coating in the porcine coronary model.

Authors:  B Scheller; A Grandt; S Wnendt; G Lorenz; M Böhm; G Nickenig
Journal:  Z Kardiol       Date:  2005-07

7.  Black hole restenosis after drug-eluting stent implantation for in-stent restenosis: potential mechanism and optimal strategy.

Authors:  Yoritaka Otsuka; Takashi Murata; Michiaki Kono; Hiroki Imoto; Taku Koyama; Keita Nakamura; Sunao Kadama; Hiroo Noguchi; Taro Saito
Journal:  Heart Vessels       Date:  2014-06-07       Impact factor: 2.037

Review 8.  Pathology of atherosclerosis and stenting.

Authors:  Frank D Kolodgie; Gaku Nakazawa; Giuseppe Sangiorgi; Elena Ladich; Allen P Burke; Renu Virmani
Journal:  Neuroimaging Clin N Am       Date:  2007-08       Impact factor: 2.264

9.  Pretreatment with intraluminal rapamycin nanoparticle perfusion inhibits neointimal hyperplasia in a rabbit vein graft model.

Authors:  Kai Liu; Guangqing Cao; Xiquan Zhang; Ruifang Liu; Weiwei Zou; Shuming Wu
Journal:  Int J Nanomedicine       Date:  2010-10-21

10.  Efficacies of the new paclitaxel-eluting Coroflex Please stent in percutaneous coronary intervention; comparison of efficacy between Coroflex Please and Taxus (ECO-PLEASANT) trial: study rationale and design.

Authors:  Jae-Bin Seo; Hui-Kyung Jeon; Kyung-Woo Park; Jong-Seon Park; Jang-Ho Bae; Sang-Wook Kim; Keon-Woong Moon; Jae-Woong Choi; Sang-Gon Lee; Woo-Young Chung; Tae-Jin Youn; Soo-Joong Kim; Doo-Il Kim; Byung-Ok Kim; Min-Su Hyon; Keum-Soo Park; Tae-Joon Cha; Hweung-Kon Hwang; Seung-Ho Hur; Hyo-Soo Kim
Journal:  Trials       Date:  2009-10-23       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.